NCT03353012 is a Phase 4 clinical trial of Etonogestrel Drug Implant in Breastfeeding, sponsored by Chulalongkorn University.

Who is sponsoring NCT03353012?

NCT03353012 is sponsored by Chulalongkorn University.

What drugs are being tested in NCT03353012?

Interventions in NCT03353012: Etonogestrel Drug Implant, Levonorgestrel Drug Implant.

What condition does NCT03353012 study?

NCT03353012 studies Breastfeeding, Post Partum.

Is NCT03353012 still recruiting?

NCT03353012 is currently completed. Last updated 26 July 2019.

Last reviewed 2019-07-26 · How we verify

NCT03353012

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant

Completed Phase 4 Last updated 26 July 2019

What this trial tests

Phase 4 trial testing Etonogestrel Drug Implant in Breastfeeding in 60 participants. Completed in 1 August 2018.

Timeline

1 January 2018

Primary endpoint
1 May 2018

1 August 2018

Quick facts

Lead sponsor	Chulalongkorn University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 January 2018
Primary completion	1 May 2018
Estimated completion	1 August 2018
Sites	1 location across Thailand

Drugs / interventions tested

Etonogestrel Drug Implant — full drug profile →
Levonorgestrel Drug Implant — full drug profile →

Conditions studied

Breastfeeding — all drugs for Breastfeeding →
Post Partum — all drugs for Post Partum →

Sponsor

Chulalongkorn University

Who can join

Adults 18 to 45, female only, with Breastfeeding or Post Partum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
Sothornwit J, Kaewrudee S, Lumbiganon P, Pattanittum P, et al · · 2022 · cited 12× · PMID 36302159 · DOI 10.1002/14651858.cd011913.pub3

Verify or expand the search:

Other recruiting trials for Breastfeeding

Currently open trials in the same condition.

NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT05377372 — Early Life Exposures Among Children With Sickle Cell Disease · NA · recruiting
NCT07341256 — Father-Focused Breastfeeding Education and Breastfeeding Outcomes · NA · recruiting
NCT07499466 — Peer-Support Breastfeeding Program for Mothers in Severe Socioeconomic Deprivation: Feasibility Study · recruiting

Other Chulalongkorn University trials

Trials by the same sponsor.

NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03353012 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
Last refreshed: 26 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353012.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing